NPPB and hydrops fetalis: A natriuretic peptide level threshold was used in PARADIGM-HF to ensure an adequate event rate in the trial and the benefit of sacubitril/valsartan over enalapril was consistent across the range of baseline NT-proBNP concentrations in PARADIGM-HF [16].